指南与共识糖尿病

提升持续葡萄糖监测系统的临床价值与效用:问题与建议:欧洲糖尿病研究协会与美国糖尿病协会糖尿病技术工作组的联合声明

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
指南 / 共识 · Diabetes Care · 2017-10-25

该联合声明回顾持续葡萄糖监测(CGM)应用15年来推广缓慢的现状,指出成本、测量可靠性、人为因素、结果展示缺乏标准化及数据用于治疗决策的不确定性等障碍,并提出临床使用与监管(上市前后)系统性改进建议,以提升安全性和有效性。

要点

  • CGM应用15年来普及仍低,多数地区日常使用比例不高。
  • 推广障碍包括成本、测量可靠性、人为因素、结果展示未标准化及数据决策不确定性。
  • 声明针对临床使用与监管上市前后处理提出系统性改进建议。

核心结论

  • 声明旨在通过系统性改进CGM临床使用与监管处理,提升安全性和有效性,以支持技术发挥改善更多糖尿病患者生活质量和健康结局的潜力。

研究设计与样本

  • 欧洲糖尿病研究协会与美国糖尿病协会糖尿病技术工作组联合科学声明。

主要发现

  • CGM系统问世已超过15年,但向愿景的进展是渐进的。
  • 全球多数地区每日使用CGM而非传统自我血糖监测的比例仍低。
  • 推广障碍包括成本、测量可靠性(尤其早期系统)、人为因素问题、结果展示缺乏标准化格式以及如何最佳利用CGM数据做治疗决策的不确定性。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionize the use of intensive insulin therapy in diabetes; however, progress toward that vision has been gradual. Although increasing, the proportion of individuals using CGM rather than conventional systems for self-monitoring of blood glucose on a daily basis is still low in most parts of the world. Barriers to uptake include cost, measurement reliability (particularly with earlier-generation systems), human factors issues, lack of a standardized format for displaying results, and uncertainty on how best to use CGM data to make therapeutic decisions. This Scientific Statement makes recommendations for systemic improvements in clinical use and regulatory (pre- and postmarketing) handling of CGM devices. The aim is to improve safety and efficacy in order to support the advancement of the technology in achieving its potential to improve quality of life and health outcomes for more people with diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Petrie JR, Peters AL, Bergenstal RM, et al. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2017. PMID: 29070577. doi:10.2337/dci17-0043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。